References

1. Aibek E. Mirrakhimov; Kingman P. Strohl; High-altitude Pulmonary Hypertension: an Update on Disease Pathogenesis and Management. The Open Cardiovascular Medicine Journal 2016, 10, 19-27, 10.2174/1874192401610010019.
2. Akanksha Agrawal; Richa Rathor; Geetha Suryakumar; Oxidative protein modification alters proteostasis under acute hypobaric hypoxia in skeletal muscles: a comprehensive in vivo study. Cell Stress and Chaperones 2017, 22, 429-443, 10.1007/s12192-017-0795-8.
3. Grzegorz Bilo; Sergio Caravita; Camilla Torlasco; Gianfranco Parati; Blood pressure at high altitude: physiology and clinical implications.. Kardiologia Polska 2019, 77, 596-603, 10.33963/KP.14832.
4. Cynthia M. Beall; Daniel Laskowski; Serpil C. Erzurum; Nitric oxide in adaptation to altitude. Free Radical Biology and Medicine 2012, 52, 1123-1134, 10.1016/j.freeradbiomed.2011.12.028.
5. Moore, LG.; Human genetic adaptation to high altitude. High Alt Med Biol. 2001, 2, 257-279, 10.1089/152702901750265341.
6. Jean-Paul Richalet; Manuel Vargas Donoso; Daniel Jimenez; Ana-María Antezana; Cristián Hudson; Guillermo Cortes; Jorge Osorio; Angelica Leon; Chilean Miners Commuting from Sea Level to 4500 m: A Prospective Study. High Altitude Medicine & Biology 2002, 3, 159-166, 10.1089/15270290260131894.
7. Fabiola León-Velarde; Marco Maggiorini; John T. Reeves; A. A. Aldashev; Ingrid Asmus; Luciano Bernardi; Ri-Li Ge; Peter Hackett; Toshio Kobayashi; Lorna G. Moore; et al.Dante PenalozaJean-Paul RichaletRobert C. RoachTianyi WuEnrique VargasGustavo Zubieta-CastilloGustavo Zubieta-Calleja Consensus Statement on Chronic and Subacute High Altitude Diseases. High Altitude Medicine & Biology 2005, 6, 147-157, 10.1089/ham.2005.6.147.
8. M.M. Hoeper; Marc Humbert; Rogerio Souza; Majdy Idrees; Steven M Kawut; Karen Sliwa; Zhi-Cheng Jing; J Simon R Gibbs; A global view of pulmonary hypertension. The Lancet Respiratory Medicine 2016, 4, 306-322, 10.1016/s2213-2600(15)00543-3.
9. U. S. V. Euler; G. Liljestrand; Observations on the Pulmonary Arterial Blood Pressure in the Cat. Acta Physiologica Scandinavica 1946, 12, 301-320, 10.1111/j.1748-1716.1946.tb00389.x.
10. Rohit Moudgil, Evangelos D Michelakis, Stephen L Archer; Hypoxic pulmonary vasoconstriction. J Appl Physiol 2005, 1, 390-403, 1152/japplphysiol.00733.2004.
11. N F Voelkel; R M Tuder; James P. Bridges; W P Arend; Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline.. American Journal of Respiratory Cell and Molecular Biology 1994, 11, 664-675, 10.1165/ajrcmb.11.6.7946395.
12. Patricia Siques; Julio Brito; Eduardo Pena; Reactive Oxygen Species and Pulmonary Vasculature During Hypobaric Hypoxia. Frontiers in Physiology 2018, 9, 865, 10.3389/fphys.2018.00865.
13. Dante Penaloza; Javier Arias-Stella; Marcelo V. Elizari; Rafael S. Acunzo; Marcela Ferreiro; The Heart and Pulmonary Circulation at High Altitudes. Circulation 2007, 115, 1132-1146, 10.1161/circulationaha.106.624544.
14. Sarita Nehra; Varun Bhardwaj; Santosh Kar; Deepika Saraswat; Chronic Hypobaric Hypoxia Induces Right Ventricular Hypertrophy and Apoptosis in Rats: Therapeutic Potential of Nanocurcumin in Improving Adaptation. High Altitude Medicine & Biology 2016, 17, 342-352, 10.1089/ham.2016.0032.
15. Eric N. Olson; Michael D. Schneider; Sizing up the heart: development redux in disease. Genes & Development 2003, 17, 1937-1956, 10.1101/gad.1110103.
16. Sheng-Huang Chang; Chung-Jung Liu; Chia-Hua Kuo; Hong Chen; Wen-Yuan Lin; Kun-Yu Teng; Chang-Hai Tsai; Fuu-Jen Tsai; Chih-Yang Huang; Bor-Show Tzang; et al.Wei-Wen KuoSheng-Wei Chang Garlic Oil Alleviates MAPKs- and IL-6-mediated Diabetes-related Cardiac Hypertrophy in STZ-induced DM Rats. Evidence-Based Complementary and Alternative Medicine 2010, 2011, 1-11, 10.1093/ecam/neq075.
17. Norbert F. Voelkel; Robert A. Quaife; Leslie A. Leinwand; Robyn J. Barst; Michael D. McGoon; Daniel R. Meldrum; Jocelyn Dupuis; Carlin S. Long; Lewis J. Rubin; Frank W. Smart; et al.Yuichiro J. SuzukiMark GladwinElizabeth M. DenholmRothy B. Gail Right Ventricular Function and Failure. Circulation 2006, 114, 1883-1891, 10.1161/circulationaha.106.632208.
18. Ruxandra Jurcuț; Kristina Haugaa; André La Gerche; The Right Ventricle: From Bench to Bedside. BioMed Research International 2018, 2018, 1-3, 10.1155/2018/2868437.
19. Baptiste Rode; Marc A Bailey; Roger Marthan; David J. Beech; Christelle Guibert; ORAI Channels as Potential Therapeutic Targets in Pulmonary Hypertension. Physiology 2018, 33, 261-268, 10.1152/physiol.00016.2018.
20. Tian-Tian Zhu; Wei-Fang Zhang; Ping Luo; Zhao-Xin Qian; Feng Li; Zheng Zhang; Changping Hu; LOX-1 promotes right ventricular hypertrophy in hypoxia-exposed rats. Life Sciences 2017, 174, 35-42, 10.1016/j.lfs.2017.02.016.
21. Sandro Malacrida; Alessandra Giannella; Giulio Ceolotto; Carlo Reggiani; Alessandra Vezzoli; Simona Mrakic-Sposta; Sarah Moretti; Rachel Turner; Marika Falla; Hermann Brugger; et al.Giacomo Strapazzon Transcription Factors Regulation in Human Peripheral White Blood Cells during Hypobaric Hypoxia Exposure: an in-vivo experimental study. Scientific Reports 2019, 9, 9901, 10.1038/s41598-019-46391-6.
22. Yibin Wang; Mitogen-activated protein kinases in heart development and diseases.. Circulation 2007, 116, 1413-23, 10.1161/CIRCULATIONAHA.106.679589.
23. R. Dale Brown; S. Kelly Ambler; Min Li; Timothy M. Sullivan; Lauren N. Henry; Joseph T. Crossno; Carlin S. Long; Timothy P. Garrington; Kurt R. Stenmark; MAP kinase kinase kinase-2 (MEKK2) regulates hypertrophic remodeling of the right ventricle in hypoxia-induced pulmonary hypertension.. American Journal of Physiology-Heart and Circulatory Physiology 2013, 304, H269-81, 10.1152/ajpheart.00158.2012.
24. Laurence Dewachter; Céline Dewachter; Inflammation in Right Ventricular Failure: Does It Matter?. Frontiers in Physiology 2018, 9, 1056, 10.3389/fphys.2018.01056.
25. Yow Keat Tham; Bianca C. Bernardo; Jenny Y. Y. Ooi; Kate L. Weeks; Julie R. McMullen; Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Archives of Toxicology 2015, 89, 1401-1438, 10.1007/s00204-015-1477-x.
26. Tsung-I Chen; Yu-Cheng Hsu; Chih-Feng Lien; Jian-Hong Lin; Hung-Wen Chiu; Kun-Ta Yang; Non-Lethal Levels of Oxidative Stress in Response to Short-Term Intermittent Hypoxia Enhance Ca2+Handling in Neonatal Rat Cardiomyocytes. Cellular Physiology and Biochemistry 2014, 33, 513-527, 10.1159/000358631.
27. Joseph R. Burgoyne; Heloise Mongue Din; Philip Eaton; Ajay M Shah; Response to "Detailed aspects of redox signaling in cardiac physiology and pathology".. Circulation Research 2013, 112, e2-e2, 10.1161/circresaha.111.300431.
28. Jessica N. Peoples; Anita Saraf; Nasab Ghazal; Tyler T. Pham; Jennifer Q. Kwong; Mitochondrial dysfunction and oxidative stress in heart disease. Experimental & Molecular Medicine 2019, 51, 1-13, 10.1038/s12276-019-0355-7.
29. Hajime Morimoto; Masafumi Takahashi; Role of Monocyte Chemoattractant Protein-1 in Myocardial Infarction. International journal of biomedical science : IJBS 2007, 3, 159-167.
30. Hiroyuki Tsutsui; Shintaro Kinugawa; Shouji Matsushima; Oxidative stress and heart failure. American Journal of Physiology-Heart and Circulatory Physiology 2011, 301, H2181-H2190, 10.1152/ajpheart.00554.2011.
31. Chi Zhang; Fan Wang; Yingxia Zhang; Yimin Kang; Haisheng Wang; Mingming Si; Liping Su; Xue Xin; Feng Xue; Fei Hao; et al.Lechu YuJinzhong XuYanlong LiuMingming Xue Celecoxib prevents pressure overload-induced cardiac hypertrophy and dysfunction by inhibiting inflammation, apoptosis and oxidative stress. Journal of Cellular and Molecular Medicine 2015, 20, 116-127, 10.1111/jcmm.12709.
32. Subir Kumar Maulik; Santosh Kumar; Oxidative stress and cardiac hypertrophy: a review. Toxicology Mechanisms and Methods 2012, 22, 359-366, 10.3109/15376516.2012.666650.
33. Akylbek Sydykov; Argen Mamazhakypov; Aleksandar Petrović; Djuro Kosanovic; Akpay S. Sarybaev; Norbert Weissmann; Hossein Ardeschir Ghofrani; Ralph T. Schermuly; Inflammatory Mediators Drive Adverse Right Ventricular Remodeling and Dysfunction and Serve as Potential Biomarkers. Frontiers in Physiology 2018, 9, 609, 10.3389/fphys.2018.00609.
34. Nicole Lüneburg; Patricia Siques; Julio Brito; Karem Arriaza; Eduardo Pena; Hans Klose; Fabiola Leon-Velarde; Rainer H. Böger; Long-Term Chronic Intermittent Hypobaric Hypoxia in Rats Causes an Imbalance in the Asymmetric Dimethylarginine/Nitric Oxide Pathway and ROS Activity: A Possible Synergistic Mechanism for Altitude Pulmonary Hypertension?. Pulmonary Medicine 2015, 2016, 1-9, 10.1155/2016/6578578.
35. IC Chiş; D Baltaru; A Dumitrovici; A Coseriu; Bc Radu; R Moldovan; A Mureşan; Protective effects of quercetin from oxidative/nitrosative stress under intermittent hypobaric hypoxia exposure in the rat’s heart. Physiology International 2018, 105, 233-246, 10.1556/2060.105.2018.3.23.
36. Alejandro Gonzalez-Candia; Marcelino Veliz; Catalina Carrasco-Pozo; Rodrigo L. Castillo; J. Cesar Cárdenas; Germán Ebensperger; Roberto V. Reyes; Aníbal J. Llanos; Emilio A. Herrera; Antenatal melatonin modulates an enhanced antioxidant/pro-oxidant ratio in pulmonary hypertensive newborn sheep. Redox Biology 2019, 22, 101128, 10.1016/j.redox.2019.101128.
37. Jayashree Karar; Karamjit S. Dolt; Manoj K. Mishra; Ehtesham Arif; Saleem Javed; M.A. Qadar Pasha; Expression and functional activity of pro-oxidants and antioxidants in murine heart exposed to acute hypobaric hypoxia. FEBS Letters 2007, 581, 4577-4582, 10.1016/j.febslet.2007.08.044.
38. Bing Zhang; Ping Zhang; Yanzhen Tan; Pan Feng; Zhengbin Zhang; Hongliang Liang; Weixun Duan; Zhenxiao Jin; Xiaowu Wang; Jincheng Liu; et al.Erhe GaoShiqiang YuDinghua YiYang SunWei Yi C1q-TNF-related protein-3 attenuates pressure overload-induced cardiac hypertrophy by suppressing the p38/CREB pathway and p38-induced ER stress.. Cell Death & Disease 2019, 10, 520-19, 10.1038/s41419-019-1749-0.
39. Nurbubu T. Moldogazieva; Innokenty M. Mokhosoev; Nataliya Feldman; Sergey Lutsenko; ROS and RNS signalling: adaptive redox switches through oxidative/nitrosative protein modifications. Free Radical Research 2018, 52, 507-543, 10.1080/10715762.2018.1457217.
40. Yi Wen; Ruohong Liu; Ning Lin; Hao Luo; Jiajia Tang; Qilin Huang; Hongyu Sun; Lijun Tang; NADPH Oxidase Hyperactivity Contributes to Cardiac Dysfunction and Apoptosis in Rats with Severe Experimental Pancreatitis through ROS-Mediated MAPK Signaling Pathway.. Oxidative Medicine and Cellular Longevity 2019, 2019, 4578175-18, 10.1155/2019/4578175.
41. Ryuichi Aikawa; Toshio Nagai; Mariko Tanaka; Yunzeng Zou; Toshimitsu Ishihara; Hiroyuki Takano; Hiroshi Hasegawa; Hiroshi Akazawa; Miho Mizukami; Ryozo Nagai; et al.Issei Komuro Reactive Oxygen Species in Mechanical Stress-Induced Cardiac Hypertrophy. Biochemical and Biophysical Research Communications 2001, 289, 901-907, 10.1006/bbrc.2001.6068.
42. Victoria C. Tu; Joe J. Bahl; Qin M. Chen; Distinct roles of p42/p44(ERK) and p38 MAPK in oxidant-induced AP-1 activation and cardiomyocyte hypertrophy.. Cardiovascular Toxicology 2002, 3, 119-134, 10.1385/ct:3:2:119.
43. M Strnisková; T Ravingerová; J Neckár; F Kolár; S Pastoreková; M Barancík; Changes in the expression and/or activation of regulatory proteins in rat hearts adapted to chronic hypoxia.. General physiology and biophysics 2006, 25, 25-41.
44. Shih-Wei Hsu; Tsu-Chung Chang; Yu-Kuan Wu; Kuen-Tze Lin; Li-Shian Shi; Shih-Yu Lee; Rhodiola crenulata extract counteracts the effect of hypobaric hypoxia in rat heart via redirection of the nitric oxide and arginase 1 pathway.. BMC Complementary and Alternative Medicine 2017, 17, 29, 10.1186/s12906-016-1524-z.
45. S. Kumar; S. M. Blake; Pharmacological Potential of p38 MAPK Inhibitors. Handbook of Experimental Pharmacology 2004, 167, 65-83, 10.1007/3-540-26670-4_4.
46. Bo Yu; Yanan Zhao; Hongli Zhang; Di Xie; Wei Nie; Kaiyao Shi; Inhibition of microRNA-143-3p attenuates myocardial hypertrophy by inhibiting inflammatory response.. Cell Biology International 2018, 42, 1584-1593, 10.1002/cbin.11053.
47. Alexandre Sarre; Norbert Lange; Pavel Kucera; Eric Raddatz; mitoKATP channel activation in the postanoxic developing heart protects E-C coupling via NO-, ROS-, and PKC-dependent pathways. American Journal of Physiology-Heart and Circulatory Physiology 2005, 288, H1611-H1619, 10.1152/ajpheart.00942.2004.
48. M. Uenoyama; S. Ogata; K. Nakanishi; F. Kanazawa; S. Hiroi; S. Tominaga; A. Seo; T. Matsui; T. Kawai; S. Suzuki; et al. Protein kinase C mRNA and protein expressions in hypobaric hypoxia-induced cardiac hypertrophy in rats. Acta Physiologica 2010, 198, 431-440, 10.1111/j.1748-1716.2009.02064.x.
49. Robert E. Carraway; Paul R. Dobner; Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2012, 1823, 544-557, 10.1016/j.bbamcr.2011.09.013.
50. Andrey V. Krylatov; Leonid N. Maslov; Nikita Voronkov; A. A. Boshchenko; Sergey V. Popov; Ludovic Gomez; Hongxin Wang; Amteshwar S. Jaggi; James M. Downey; Reactive Oxygen Species as Intracellular Signaling Molecules in the Cardiovascular System. Current Cardiology Reviews 2018, 14, 290-300, 10.2174/1573403x14666180702152436.
51. Xiang Song; Xiaoqian Qian; Ming Shen; Rong Jiang; Mary B. Wagner; Guoliang Ding; Guangping Chen; Baozhong Shen; Protein kinase C promotes cardiac fibrosis and heart failure by modulating galectin-3 expression. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2015, 1853, 513-521, 10.1016/j.bbamcr.2014.12.001.
52. Abhinav Diwan; Gerald W. Dorn; Decompensation of Cardiac Hypertrophy: Cellular Mechanisms and Novel Therapeutic Targets. Physiology 2007, 22, 56-64, 10.1152/physiol.00033.2006.
53. Zhancui Dang; Shanshan Su; Guoen Jin; Xingmei Nan; Lan Ma; Zhanqiang Li; Dianxiang Lu; Ri-Li Ge; Tsantan Sumtang attenuated chronic hypoxia-induced right ventricular structure remodeling and fibrosis by equilibrating local ACE-AngII-AT1R/ACE2-Ang1-7-Mas axis in rat. Journal of Ethnopharmacology 2020, 250, 112470, 10.1016/j.jep.2019.112470.
54. B. Kojonazarov; Tatyana Novoyatleva; Mario Boehm; Chris M. Happé; Zaneta Sibinska; Xia Tian; Amna Sajjad; Himal Luitel; Philipp Kriechling; Guido Posern; et al.Steven M. EvansFriedrich GrimmingerHossein Ardeschir GhofraniNorbert WeissmannHarm J. BogaardWerner SeegerRalph T. Schermuly p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy. American Journal of Respiratory Cell and Molecular Biology 2017, 57, 603-614, 10.1165/rcmb.2016-0374oc.
55. Karen E. Porter; Neil A. Turner; Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacology & Therapeutics 2009, 123, 255-278, 10.1016/j.pharmthera.2009.05.002.
56. Jia-Hong Wang; Lan Zhao; Xin Pan; Nan-Nan Chen; Jian Chen; Qun-Lin Gong; Feng Su; Jian Yan; Yan Zhang; Shao-Heng Zhang; et al. Erratum: Hypoxia-stimulated cardiac fibroblast production of IL-6 promotes myocardial fibrosis via the TGF-β1 signaling pathway. Laboratory Investigation 2016, 96, 1035-1035, 10.1038/labinvest.2016.84.
57. Jennifer Baum; Heather S. Duffy; Fibroblasts and Myofibroblasts: What Are We Talking About?. Journal of Cardiovascular Pharmacology 2011, 57, 376-379, 10.1097/fjc.0b013e3182116e39.
58. Maarten Hulsmans; Flora Sam; Matthias Nahrendorf; Monocyte and macrophage contributions to cardiac remodeling. Journal of Molecular and Cellular Cardiology 2016, 93, 149-155, 10.1016/j.yjmcc.2015.11.015.
59. Havovi Chichger; Alexander Vang; Kelly A. O'connell; Peng Zhang; Ulrike Mende; Elizabeth O. Harrington; Gaurav Choudhary; PKC δ and βII regulate angiotensin II-mediated fibrosis through p38: a mechanism of RV fibrosis in pulmonary hypertension.. American Journal of Physiology-Lung Cellular and Molecular Physiology 2015, 308, L827-36, 10.1152/ajplung.00184.2014.
60. Maulik D. Majmudar; Edmund J. Keliher; Timo Heidt; Florian Leuschner; Jessica Truelove; Brena F. Sena; Rostic Gorbatov; Yoshiko Iwamoto; Partha Dutta; Gregory R. Wojtkiewicz; et al.Gabriel CourtiesMatt SebasAnna BorodovskyKevin FitzgeraldMarc W. NolteGerhard DickneiteJohn W. ChenDaniel G. AndersonFilip K. SwirskiRalph WeisslederMatthias Nahrendorf Monocyte-directed RNAi targeting CCR2 improves infarct healing in atherosclerosis-prone mice. Circulation 2013, 127, 2038-2046, 10.1161/CIRCULATIONAHA.112.000116.
61. Anthony S. Jaipersad; Gregory Y.H. Lip; Stanley Silverman; Eduard Shantsila; The Role of Monocytes in Angiogenesis and Atherosclerosis. Journal of the American College of Cardiology 2014, 63, 1-11, 10.1016/j.jacc.2013.09.019.
62. Santosh Kumar; Gang Wang; Na Zheng; Wanwen Cheng; Kunfu Ouyang; Hairuo Lin; Yulin Liao; Jie Liu; HIMF (Hypoxia-Induced Mitogenic Factor)-IL (Interleukin)-6 Signaling Mediates Cardiomyocyte-Fibroblast Crosstalk to Promote Cardiac Hypertrophy and Fibrosis.. Hypertension 2019, 73, 1058-1070, 10.1161/HYPERTENSIONAHA.118.12267.
63. Linlin Jing; Jin Shao; Wei Sun; Ting Lan; ZhengPing Jia; Huiping Ma; Haibo Wang; Protective effects of two novel nitronyl nitroxide radicals on heart failure induced by hypobaric hypoxia. Life Sciences 2020, 248, 116481, 10.1016/j.lfs.2019.05.037.
64. Harm J. Bogaard; Kohtaro Abe; Anton Vonk Noordegraaf; Norbert F. Voelkel; The Right Ventricle Under Pressure. Chest 2009, 135, 794-804, 10.1378/chest.08-0492.
65. Antonino Nicoletti; J B Michel; Cardiac fibrosis and inflammation: interaction with hemodynamic and hormonal factors.. Cardiovascular Research 1999, 41, 532-543, 10.1016/S0008-6363(98)00305-8.
66. Yun-Ching Fu; Ching-Shiang Chi; Sui-Chu Yin; Betau Hwang; Yung-Tsung Chiu; Shih-Lan Hsu; Norepinephrine induces apoptosis in neonatal rat cardiomyocytes through a reactive oxygen species?TNF$alpha;?caspase signaling pathway. Cardiovascular Research 2004, 62, 558-567, 10.1016/j.cardiores.2004.01.039.
67. Xinyu Li; Quyan Zhang; M I Nasser; Linyong Xu; Xueyan Zhang; Ping Zhu; Qingnan He; Mingyi Zhao; Oxygen homeostasis and cardiovascular disease: A role for HIF?. Biomedicine & Pharmacotherapy 2020, 128, 110338, 10.1016/j.biopha.2020.110338.
68. Deepak Bhatia; Mohammad Sanaei Ardekani; Qiwen Shi And Shahrzad Movafagh; Hypoxia and its Emerging Therapeutics in Neurodegenerative, Inflammatory and Renal Diseases. Hypoxia and Human Diseases 2017, 1, 404-443, 10.5772/66089.
69. Sarita Nehra; Varun Bhardwaj; Anju Bansal; Deepika Saraswat; Combinatorial therapy of exercise-preconditioning and nanocurcumin formulation supplementation improves cardiac adaptation under hypobaric hypoxia. Journal of Basic and Clinical Physiology and Pharmacology 2016, 28, 443-453, 10.1515/jbcpp-2016-0134.
70. Manimaran, Manickam; RajkumarTulsawani; Duraisamy Arul, Joseph; Vishal, Jain; Kshipra, Misra; Protective efficacy of Hippophae rhamnoides L. extract exhibited in rat heart against hypobaric hypoxia is possibly mediated by configurations in JAK/STAT pathway. Indian J. Exp. Biol. 2019, 57, 390-398, http://nopr.niscair.res.in/handle/123456789/47442.
71. Qingshu Wang; Ling Hu; Yu Hu; Gu Gong; Hua Tan; Li Deng; Xiaoqin Sun; Xiaobo Yi; Yangyang Sun; Wei Wu; et al.Tao Li Carbon Monoxide-Saturated Hemoglobin-Based Oxygen Carriers Attenuate High-Altitude-Induced Cardiac Injury by Amelioration of the Inflammation Response and Mitochondrial Oxidative Damage. Cardiology 2016, 136, 180-191, 10.1159/000448652.
72. Yun-Yun He; Chun-Lei Liu; Xin Li; Rui-Jun Li; Li-Li Wang; Kun-Lun He; Salubrinal attenuates right ventricular hypertrophy and dysfunction in hypoxic pulmonary hypertension of rats. Vascular Pharmacology 2016, 87, 190-198, 10.1016/j.vph.2016.09.009.
73. Yali Wang; Feng Wu; Feng Hu; Yunjiang Wu; Jun Zhou; Yan Xu; Xiangrong Shao; Tao Hu; Drag-reducing polymers attenuates pulmonary vascular remodeling and right ventricular dysfunction in a rat model of chronic hypoxia-induced pulmonary hypertension. Clinical Hemorheology and Microcirculation 2020, 74, 189-200, 10.3233/ch-190668.
74. Jie Ren; Wei Liu; Guang-Cai Li; M. Jin; Zhen-Xi You; Hui-Guo Liu; Yi Hu; Atorvastatin Attenuates Myocardial Hypertrophy Induced by Chronic Intermittent Hypoxia In Vitro Partly through miR-31/PKCε Pathway. Current Medical Science 2018, 38, 405-412, 10.1007/s11596-018-1893-2.